| Authors: |
Smallbone P; The University of Texas, MD Anderson Cancer Centre, Department of Stem Cell Transplantation and Cellular Therapy., Shigle TL; The University of Texas, MD Anderson Cancer Centre, Division of Pharmacy., Paslovsky O; The University of Texas, MD Anderson Cancer Centre, Department of Lymphoma and Myeloma., Hosing C; The University of Texas, MD Anderson Cancer Centre, Department of Stem Cell Transplantation and Cellular Therapy., Alousi A; The University of Texas, MD Anderson Cancer Centre, Department of Stem Cell Transplantation and Cellular Therapy., Bashir Q; The University of Texas, MD Anderson Cancer Centre, Department of Stem Cell Transplantation and Cellular Therapy., Aljawai Y; The University of Texas, MD Anderson Cancer Centre, Department of Stem Cell Transplantation and Cellular Therapy., Ramdial J; The University of Texas, MD Anderson Cancer Centre, Department of Stem Cell Transplantation and Cellular Therapy., Popat U; The University of Texas, MD Anderson Cancer Centre, Department of Stem Cell Transplantation and Cellular Therapy., Champlin R; The University of Texas, MD Anderson Cancer Centre, Department of Stem Cell Transplantation and Cellular Therapy., Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Centre,., Oran B; The University of Texas, MD Anderson Cancer Centre, Department of Stem Cell Transplantation and Cellular Therapy. boran@mdanderson.org. |
